final analysis of uvea-ixa study of ixazomib in r/r myeloma
Published 3 years ago • 56 plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
3:14
uvea-ixa: ixazomib-based therapy in r/r myeloma treated via european early access program
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
2:25
icaria-mm: final os analysis
-
4:03
ikema long-term sub-group analysis: isa-kd for 1q21 multiple myeloma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:05
updated phase i results from sgnbcma-001 study of sea-bcma in patients with r/r multiple myeloma
-
14:06
interpreting myeloma tests- case studies
-
23:21
characteristics of a patient other ep 12
-
24:46
sumit verma of iovance biotherapeutics - 1 time therapy for solid tumors
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
0:45
difference between quality of life & patient-reported outcomes
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
2:53
mrd evaluation during ixazomib maintenance in myeloma
-
4:12
insight-mm: real-world patterns of patient characteristics
-
5:07
daratumumab in the management of al amyloidosis
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing